BSPM [Biostar Pharmaceuticals,] 8-K: Biostar Pharmaceuticals, Regainsmpliance With NASDAQ $1.00 Minimum Bid

[Biostar Pharmaceuticals, Regainsmpliance With NASDAQ $1.00 Minimum Bid Price Rule BSPM XIANYANG, China, Nov. 13, 2013 /PRNewswire/ -- Biostar Pharmaceuticals, ( Ronghua Wang, Biostar's Chairman,mmenting on the announcement, stated: "We strongly believe that regainingmpliance with NASDAQ'sntinued listing requirements is an important achievement for thempany. Having resolved this issue, wenntinue focusing on maximizing shareholder value and]

By | 2016-02-07T15:07:46+00:00 November 14th, 2013|Categories: BSPM, Chinese Stocks, Webplus ver|Tags: , , , , , |0 Comments
Read More

CPHI [CHINA PHARMAS,] DEFA14A: (Original Filing)

[Payment of Filing Fee (Check the appropriate box): No fee required. o Feemputed on table below per Exchange Act Rules14a-6(i)(1) and 0-11. (1) Title of each class of securities to which transaction applies: (2)gregate number of securities to which transaction applies: (3) (4) Proposed maximumgregate value of transaction:]

By | 2016-02-07T21:30:11+00:00 November 6th, 2013|Categories: Chinese Stocks, CPHI, SEC Original|Tags: , , , , , |0 Comments
Read More

CPHI [CHINA PHARMAS,] DEFA14A: Payment of Filing Fee (Check the appropriate box):

[Payment of Filing Fee (Check the appropriate box): No fee required. o Feemputed on table below per Exchange Act Rules14a-6(i)(1) and 0-11. (1) Title of each class of securities to which transaction applies: (2)gregate number of securities to which transaction applies: (3) (4) Proposed maximumgregate value of transaction:]

By | 2016-02-07T21:31:07+00:00 November 6th, 2013|Categories: Chinese Stocks, CPHI, Webplus ver|Tags: , , , , , |0 Comments
Read More
Skip to toolbar